Clinical Trial Update: A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II multicenter study evaluating neoadjuvant therapy with a PD-1 inhibitor in combination with chemotherapy for locally advanced laryngeal and hypopharynge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Cancer
• Laryngeal Cancer

Drugs mentioned

• PD-1 inhibitor plus chemotherapy (neoadjuvant)

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Head and Neck Cancers | Phase 2 | Status: NOT_YET_RECRUITING